OneSource Specialty Pharma Ltd (ONESOURCE) — Announcement | 31 August 2026

· BSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Company schedules analyst meeting for September 3, 2026
💡 Investor Takeaway
Investors can attend the meeting to hear the company's growth outlook and strategy directly.

OneSource Specialty Pharma announced an in-person analyst and institutional investor meeting on September 3, 2026, at its manufacturing facility in Doddaballapura, Bengaluru Rural District, to discuss business overview, strategy, industry trends, and growth outlook without sharing any unpublished price sensitive information.

📄 View Original Announcement (PDF)

About OneSource Specialty Pharma Ltd (ONESOURCE)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹17,366.55 Cr ROE: -0.8% ROCE: 0.9%

View full ONESOURCE stock details →

📡 Get AI alerts when ONESOURCE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ONESOURCE — Free

📊 More ONESOURCE filings

See all ONESOURCE filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ONESOURCE files new disclosures

Track ONESOURCE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ONESOURCE — Free

Free account · 2 AI queries/day